Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia-Reference-Cited by-同舟云学术

Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia

Published:1984-03 Issue:3 Volume:56 Page:399-407
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Preisler H. D.,Azarnia N.,Raza A.,Grunwald H.,Vogler R.,Browman G.,Goldberg J.,Chervenick P.,Miller K.,Brennan J.,Winton L.,and R. Joyce,Gottlieb(Intergroup Leukemia Study) A.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1984.tb03970.x/fullpdf

Reference27 articles.

1. Blast cell kinetics and prognosis in acute nonlymphocytic leukemia

2. Z. Arlin, T. Gee, M. Dowling, J. Campbell, and B. Clarkson(1976 ) Significance of pulse3H-thymidine labeling index (LI) in adult acute myeloid leukemia .Proceedings of the American Society of Clinical Oncology, (Abstract), C-239.

3. Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

4. Factors influencing prognosis in adults with acute myelogenous leukaemia

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome;British Journal of Haematology;2018-04-20

2. Cell cycle status in AML blast cells from peripheral blood, bone marrow aspirates and trephines and implications for biological studies and treatment;British Journal of Haematology;2016-04-08

3. Adult acute non-lymphoblastic leukaemia: reliability and prognostic significance of pretreatment bone marrow S-phase size determined by flow cytofluorometry;Scandinavian Journal of Haematology;2009-04-24

4. Prognostic significance of peripheral blood S + G2/M phase size in adult acute non-lymphoblastic leukaemia;European Journal of Haematology;2009-04-24

5. Poor prognosis acute myelogenous leukemia 2 — biological and molecular biological characteristics and treatment outcome;Leukemia Research;2000-09